Stocks go up and down with the market and fundamental factors, but, as an asset class, they tend to outperform more ...

David Jagielski (Pfizer): Pfizer is one of the biggest no-brainer stocks in healthcare right now. Between its low valuation, ...

He stated that there are some concerns that arise when one looks at the S&P technicals, such as the seasonal weakness that ...

The landlord sits at the crossroads of two megatrends. There's a nearly $50 trillion need for stable and growing income to ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Investors interested in betting against the market consensus can express a contrarian thesis with these unique ETFs.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

VRT, MTZ and HOOD stand out as momentum picks, combining strong yearly gains with recent pullbacks for potential entry points ...

On August 29, Drew Matus, Chief Market Strategist at MetLife Investment Management, joined CNBC to discuss the markets and share his view of the current economy.

What’s Happening With KDP Stock? Looking at valuation per dollar of sales or profit, BAX stock appears inexpensive relative ...